TipRanks
Corvus Pharmaceuticals Inc (DE:C17)
FRANKFURT:C17
Germany Market
C17
Corvus Pharmaceuticals
RESEARCH TOOLSreports

Corvus Pharmaceuticals (C17) Balance Sheet

0 Followers

Corvus Pharmaceuticals Balance Sheet

Corvus Pharmaceuticals's total assets for Q2 2026 were $239.27M, a decrease of -5.50% from the previous quarter. DE:C17 total liabilities were $13.95M for the fiscal quarter, a 11.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 71.12M$ 68.91M$ 45.55M$ 68.24M$ 109.45M
Total Liabilities
$ 9.91M$ 36.34M$ 6.87M$ 12.13M$ 12.29M
Total Equity Gross Minority
$ 61.20M$ 32.57M$ 38.68M$ 56.12M$ 97.16M
Other Metrics
Currency in USD

Corvus Pharmaceuticals Debt to Assets